Insight journal - Company

Actelion: Partnering activity 2009-2014

Posted on 10 February 2014

Tags: , ,

Actelion, a big biotech company based in Switzerland, has a fully integrated business model focused on innovative treatments to serve high unmet medical needs. Actelion has sought partnerships in the respiratory, cardiovascular, oncology therapy areas in the past and is continuing to seek partners to bolster its presence.

Abstracted from: Partnering Agreements with Actelion 2009-2014

The number of partnering, collaborative R&D and licensing deals is fairly consistent since 2009.

Actelion unlike other big biotech companies is not very active in dealmaking activity.  The following figure shows the level of Actelion partnering deal announcements since 2009.

Figure 1: Actelion partnering deals 2009-2014

Actelion: Partnering activity 2009-2014

Actelion: Partnering activity 2009-2014

Source: Current Agreements, 2014

Analysis of the partnering deals shows a strong emphasis on partnerships in respiratory, cardiovascular and oncology diseases.

The following table provides an overview of the partnering deals announced by Actelion based on therapy area disclosed. Our report provides a more detailed insight into the precise therapeutic target of each deal. See: Partnering Agreements with Actelion 2009-2014

Figure 2: Actelion partnering deals by therapy area 2009-2014

Figure 2: Actelion partnering deals by therapy area 2009-2014

Figure 2: Actelion partnering deals by therapy area 2009-2014

 

Source: Current Agreements, 2014

Further analysis of these deals shows that Actelion has a preference for supply, licensing, and distribution deals similar to many other top big biotech companies. Such partnering deals provide the right for Actelion to exploit the licensors technology in return for payment of upfront, development and sales, and royalty payments.

The following table provides an overview of the partnering deals announced by Actelion based on deal type disclosed.

Figure 3: Actelion partnering deals by deal type 2009-2014

 

Figure 3: Actelion partnering deals by deal type 2009-2014

Figure 3: Actelion partnering deals by deal type 2009-2014

Source: Current Agreements, 2013

When looking at the stage of development of partnering at the deal signing stage, the most popular stage at signing is marketed with 5 deal announcements.

The following table provides an overview of the partnering deals announced by Actelion based on stage of development at signature.                                                                                                          

Figure 4: Actelion partnering by stage of development 2009-2014

Figure 4: Actelion partnering by stage of development 2009-2014

Figure 4: Actelion partnering by stage of development 2009-2014

Source: Current Agreements, 2014

Actelion has signed about 10 partnering, collaborative R&D and licensing deals since 2009. The following shows the top two deals by headline value.

Figure 5: Top Actelion partnering deals by headline value 2009-2014

Figure 5: Top Actelion partnering deals by headline value 2009-2014

Source: Current Agreements, 2014

Our report provides more detailed insight into the details of each deal. See: Partnering Agreements with Actelion 2009-2014

Actelion partnering at Current Agreements

View all partnering deals for Actelion: 2014 | 2013 | 20122011 | 2010 | 2009

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Agreements with Actelion 2009-2014

More

Summary profile data for Actelion

Partnering interests for Actelion

M&A activity for Actelion

 

Available reports from Current Partnering

Report: Partnering Agreements with Actelion 2009-2014

Report: Partnering Deals and Alliances with Big Biotech

 

Available resources for deal coverage for Actelion

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Actelion company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply